Dr. Lang is the Senior Vice President and Head of Medical Affairs and Pharmacovigilance at Bayer Healthcare China including Hong Kong.  In this role, Dr. Lang directs the Medical Affairs, Medical Science Liaisons, Medical Communications, Scientific Operations, Medical Compliance, Patient Support and Disease Management Programs, Health Economics and Outcome Research and Pharmacovigilance. Prior to coming to Bayer China, Dr. Lang worked in Bayer’s Global Medical Affairs Oncology in the United States.  Dr. Lang has over 18 years of pharmaceutical industry experiences ranging from early and late stage clinical development to medical affairs.  Dr. Lang held positions with increasing responsibilities at Endo Pharmaceuticals, Johnson and Johnson, Wyeth and Novo Nordisk.  Dr. Lang is a board-certified oncologist and hematologist.  He received his medical education at the Fourth Military Medical University in Xi’an and PhD in Biochemistry at Rush University in Chicago.